Drugs / Etoreat
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01968005 | Nov 2013 → May 2014 | — | MEDRx USA, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Etoreat | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01968005 ↗ |
| Known as | Etodolac-Lidocaine Topical Patch | “Etoreat®(Etodolac-Lidocaine Topical Patch)” NCT01968005 ↗ |
| Route | Topical | “Etoreat®(Etodolac-Lidocaine Topical Patch)” NCT01968005 ↗ |